| Literature DB >> 33324474 |
M Hossein Aghdaie1, N Azarpira1, A Shamsaeefar2, N Motazedian1, M Kaviani1, E Esfandiari1, S Golbabapour1, S Nikeghbalian2, K Kazemi2, H Salahi2, S A Malek-Hosseini2, B Geramizadeh1,3.
Abstract
BACKGROUND: Hepatocyte transplantation using isolated human hepatocytes is an alternative source that can be used for the treatment of metabolic diseases and acute liver failure as a time bridge to liver transplantation. These cells can also be used for bioartificial liver systems and in vitro study of drug toxicity.Entities:
Keywords: Cryopreservation; Hepatocytes; Liver transplantation
Year: 2020 PMID: 33324474 PMCID: PMC7724769
Source DB: PubMed Journal: Int J Organ Transplant Med ISSN: 2008-6482
Characteristics of liver tissue donors used for isolation of hepatocytes
| No | Sex | Age (yrs) | Cold ischemic time (hrs) | Yield of cells (×106) | Percentage of steatosis | Pathological problem |
|---|---|---|---|---|---|---|
| 1 | F | 36 | 44 | 0.79 | 20% microvesicular, 10% macrovesicular | Atherosclerosis |
| 2 | M | 8 | 22 | 6.46 | — | Crigler Najjar |
| 3 | M | 1.3 | 22 | 14.12 | — | Crigler Najjar |
| 4 | M | 2 | 12 | 15.44 | — | Crigler Najjar |
| 5 | F | 1.7 | 23 | 8.06 | — | Crigler Najjar |
Composition of Cold Preservation Solutions
| Solution | UW | Vitamin E (100 µM/L) | Deferoxamine (1 mM/L) | HSA (5%) | PEG (1%) | CsA (1 µM/L) | α-Lipoic acid (5 mM/L) | UDCA (0.5 mM/L) |
|---|---|---|---|---|---|---|---|---|
| 1 | + | – | – | – | – | – | – | |
| 2 | + | + | + | + | + | + | – | – |
| 3 | + | – | – | – | – | – | + | + |
| 4 | + | + | + | + | + | + | + | + |
| WEM | – | – | – | – | – | – | – | – |
HSA: Human serum albumin; PEG: Polyethylene glycol; CsA: Cyclosporine A; UW: University of Wisconsin; UDCA: Ursodeoxycholic acid; WEM: 500 mL Williams E medium supplemented with 32 U/L insulin, 0.9 mg/L dexamethasone, penicillin-streptomycin (5 mL), L-glutamine (5 mL), and 1 M HEPES (5 mL)
Figure 1Flowchart of experimental design. Hepatocytes were cultured in 24-well collagen-coated plates at 37 °C for 24 hrs; then cold preserved at 4 °C for 24 hrs. After cold preservation hepatocytes were cultured in serum free WEM at 37 °C for 24 hrs. Then, albumin and urea production were determined. Morphology assessment was performed after 24 hrs and 72 hrs as the controls, immediately after cold preservation and rewarming the cells 24 hrs at 37 °C
Figure 2Morphology of cultured human hepatocytes after 24 hrs of hypothermic storage (4 °C) and rewarming. Cultured cells stored at 4 °C in serum free Williams E medium (WEM) (C, D) and University of Wisconsin (UW) solution (E, F) and rewarmed in serum free WEM for 24 hrs at 37 °C and 5% CO2. Morphological assessment was performed by phase contrast microscopy immediately after cold storage (C, E) and after rewarming (D, F). Control cells incubated for 24 hrs (A) and 72 hrs (B) at 37 °C and 5% CO2. Bleb formation (arrowhead), apoptotic bodies (thick arrows), nuclei condensation (thin arrows) and vacuolization (dashed arrow) are shown
Figure 3Morphology of cultured human hepatocytes after 24 hrs of hypothermic storage (4 °C) and rewarming. Cultured cells stored at 4 °C in different cold preservation solutions and rewarmed in serum free Williams E medium for 24 hrs at 37 °C and 5% CO2. Solution 2 (A, B), solution 3 (C, D), solution 4 (E, F): morphological assessment was performed by phase-contrast microscopy immediately after cold storage (A, C, E) and after rewarming (B, D, F). Bleb formation (arrowhead), nuclei condensation (thin arrows) and vacuolization (dashed arrow) are shown
Comparison of albumin production in cultured isolated human hepatocytes in different preservation solutions with control 24 h and 72 h hepatocytes
| Studied group | Albumin (ng/mL), Mean±SD | Mean rank | p value ( | p value ( |
|---|---|---|---|---|
| Control 24 h | 424.73±205.21 | 29.20 | ||
| Control 72 h | 253.55±76.72 | 23.60 | 0.388 | |
| Solution 1 | 115.49±46.00 | 13.20 | 0.014 | 0.109 |
| Solution 2 | 191.20±53.50 | 18.80 | 0.109 | 0.460 |
| Solution 3 | 59.86±31.62 | 7.80 | 0.001 | 0.015 |
| Solution 4 | 369.79±93.79 | 29.60 | 0.951 | 0.355 |
| WEM | 27.18±17.94 | 3.80 | 0.001 | 0.002 |
Solution 1: University of Wisconsin (UW); Solution 2: UW+(vitamin E 100 µM/L, deferoxamine 1 mM/L, human serum albumin (HSA) 5%, polyethylene glycol (PEG) 1%, and cyclosporine (CsA) 1 µM/L); Solution 3: UW+(α-lipoic acid 5 mM/L, ursodeoxycholic acid (UDCA) 0.5 mM/L); Solution 4: substances of solutions 2 and 3; WEM: serum free Williams E medium. Kruskal-Wallis test and pairwise comparison were performed (n=5).
Figure 4Schematic diagram of experimental steps showing the relationship between different cold storage solutions and the amount of albumin and urea production. After hepatocyte isolation, they were cultured and allocated to different cold storage groups. After 24 hrs of storage at 4 °C, they were rewarmed at 37 °C and their albumin and urea production were measured
Comparison of urea production in cultured isolated human hepatocytes in different preservation solutions with control 24 h and 72 h hepatocytes
| Studied group | Urea(mg/dL), Mean±SD | Mean rank | p value ( | p value ( |
|---|---|---|---|---|
| Control 24 h | 12.04±4.46 | 31.60 | ||
| Control 72 h | 5.50±3.75 | 23.60 | 0.22 | |
| Solution 1 | 4.29±3.87 | 20.20 | 0.079 | 0.600 |
| Solution 2 | 2.41±2.20 | 15.00 | 0.010 | 0.185 |
| Solution 3 | 2.67±2.75 | 15.60 | 0.014 | 0.217 |
| Solution 4 | 0.81±0.54 | 9.20 | 0.001 | 0.026 |
| WEM | 1.33±1.60 | 10.80 | 0.001 | 0.048 |
Solution 1: University of Wisconsin (UW); Solution 2: UW+(vitamin E 100 µM/L, deferoxamine 1 mM/L, human serum albumin (HSA) 5%, polyethylene glycol (PEG) 1%, and cyclosporine (CsA) 1 µM/L); Solution 3: UW+(α-lipoic acid 5 mM/L, ursodeoxycholic acid (UDCA) 0.5 mM/L); Solution 4: substances of solutions 2 and 3; WEM: serum free Williams E medium. Kruskal-Wallis test and pairwise comparison were performed (n=5).